245 related articles for article (PubMed ID: 19040234)
1. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Shin J; Anisur RM; Ko MK; Im GH; Lee JH; Lee IS
Angew Chem Int Ed Engl; 2009; 48(2):321-4. PubMed ID: 19040234
[No Abstract] [Full Text] [Related]
2. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Na HB; Lee JH; An K; Park YI; Park M; Lee IS; Nam DH; Kim ST; Kim SH; Kim SW; Lim KH; Kim KS; Kim SO; Hyeon T
Angew Chem Int Ed Engl; 2007; 46(28):5397-401. PubMed ID: 17357103
[No Abstract] [Full Text] [Related]
3. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging.
Kim T; Cho EJ; Chae Y; Kim M; Oh A; Jin J; Lee ES; Baik H; Haam S; Suh JS; Huh YM; Lee K
Angew Chem Int Ed Engl; 2011 Nov; 50(45):10589-93. PubMed ID: 21928456
[No Abstract] [Full Text] [Related]
4. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
Huang CC; Khu NH; Yeh CS
Biomaterials; 2010 May; 31(14):4073-8. PubMed ID: 20149451
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
7. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics.
Ren Q; Yang K; Zou R; Wan Z; Shen Z; Wu G; Zhou Z; Ni Q; Fan W; Hu J; Liu Y
Nanoscale; 2019 Dec; 11(47):23021-23026. PubMed ID: 31774090
[TBL] [Abstract][Full Text] [Related]
9. Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform.
Ha TL; Kim HJ; Shin J; Im GH; Lee JW; Heo H; Yang J; Kang CM; Choe YS; Lee JH; Lee IS
Chem Commun (Camb); 2011 Aug; 47(32):9176-8. PubMed ID: 21761053
[TBL] [Abstract][Full Text] [Related]
10. Integration of Polymerization and Biomineralization as a Strategy to Facilely Synthesize Nanotheranostic Agents.
Xiao B; Zhou X; Xu H; Wu B; Hu D; Hu H; Pu K; Zhou Z; Liu X; Tang J; Shen Y
ACS Nano; 2018 Dec; 12(12):12682-12691. PubMed ID: 30507161
[TBL] [Abstract][Full Text] [Related]
11. Porous magnetic manganese oxide nanostructures: synthesis and their application in water treatment.
Chen H; Chu PK; He J; Hu T; Yang M
J Colloid Interface Sci; 2011 Jul; 359(1):68-74. PubMed ID: 21507410
[TBL] [Abstract][Full Text] [Related]
12. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.
Zhu P; Chen Y; Shi J
ACS Nano; 2018 Apr; 12(4):3780-3795. PubMed ID: 29613770
[TBL] [Abstract][Full Text] [Related]
13. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
14. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging.
Bae KH; Lee K; Kim C; Park TG
Biomaterials; 2011 Jan; 32(1):176-84. PubMed ID: 20934746
[TBL] [Abstract][Full Text] [Related]
15. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
16. Mn(II)-containing coordination nanoparticles as highly efficient T(1) contrast agents for magnetic resonance imaging.
Paul G; Prado Y; Dia N; Rivière E; Laurent S; Roch M; Elst LV; Muller RN; Sancey L; Perriat P; Tillement O; Mallah T; Catala L
Chem Commun (Camb); 2014 Jun; 50(51):6740-3. PubMed ID: 24829060
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO
Lin LS; Song J; Song L; Ke K; Liu Y; Zhou Z; Shen Z; Li J; Yang Z; Tang W; Niu G; Yang HH; Chen X
Angew Chem Int Ed Engl; 2018 Apr; 57(18):4902-4906. PubMed ID: 29488312
[TBL] [Abstract][Full Text] [Related]
18. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
19. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging.
Bae KH; Lee K; Lee J; Lee IS; Lee JH; Park TG
J Control Release; 2011 Nov; 152 Suppl 1():e133-4. PubMed ID: 22195802
[No Abstract] [Full Text] [Related]
20. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
Li Z; Wang SX; Sun Q; Zhao HL; Lei H; Lan MB; Cheng ZX; Wang XL; Dou SX; Max Lu GQ
Adv Healthc Mater; 2013 Jul; 2(7):958-64. PubMed ID: 23322490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
